|
GB202005494D0
|
|
Induced pluripotent cell comprising a contollable transgene for conditional immortalisation
|
|
GB201919021D0
|
|
Nucleic acid constructs for delivering polynucleotides into exosomes
|
|
WO2020074925A2
|
|
Induced pluripotent cell comprising a controllable transgene for conditional immortalisation
|
|
GB201911464D0
|
|
Genetic modification site
|
|
GB201816934D0
|
|
Stem cells
|
|
GB201816670D0
|
|
Stem cells
|
|
US2020108100A1
|
|
Neural stem cell therapy for stroke
|
|
GB201716408D0
|
|
Stem cell microparticles for cancer therapy
|
|
KR20160035087A
|
|
Stem cell microparticles and mirna
|
|
WO2014125277A1
|
|
Method of producing microparticles
|
|
GB201317888D0
|
|
Method and product
|
|
GB201317889D0
|
|
Product and use
|
|
GB201317887D0
|
|
Product
|
|
GB201314573D0
|
|
Product
|
|
SG11201500329WA
|
|
Stem cell microparticles
|
|
EP2833893A1
|
|
Stem cell microparticles
|
|
GB201302468D0
|
|
Stem cell product
|
|
GB201212848D0
|
|
Stem cell product
|
|
GB201205972D0
|
|
Stem cell product
|
|
GB201011589D0
|
|
Therapeutic cells
|
